Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Income from Non-Controlling Interests (2021 - 2025)

PAVmed (PAVM) has 5 years of Income from Non-Controlling Interests data on record, last reported at -$629000.0 in Q3 2025.

  • For Q3 2025, Income from Non-Controlling Interests changed N/A year-over-year to -$629000.0; the TTM value through Sep 2025 reached -$1.7 million, changed N/A, while the annual FY2024 figure was -$11.4 million, 24.68% up from the prior year.
  • Income from Non-Controlling Interests reached -$629000.0 in Q3 2025 per PAVM's latest filing, down from -$402000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at -$289000.0 in Q4 2024 and bottomed at -$4.3 million in Q1 2023.
  • Average Income from Non-Controlling Interests over 5 years is -$2.5 million, with a median of -$3.0 million recorded in 2022.
  • Peak YoY movement for Income from Non-Controlling Interests: crashed 306.63% in 2022, then skyrocketed 91.43% in 2024.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at -$2.5 million in 2021, then plummeted by 67.09% to -$4.1 million in 2022, then rose by 18.0% to -$3.4 million in 2023, then surged by 91.43% to -$289000.0 in 2024, then tumbled by 117.65% to -$629000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Non-Controlling Interests were -$629000.0 in Q3 2025, -$402000.0 in Q2 2025, and -$345000.0 in Q1 2025.